Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Alprolix for the Treatment of Haemophilia B

Drug Name (Brand / Generic)

Alprolix / Coagulation Factor IX (Recombinant), Fc Fusion Protein

Company / Licensee

Biogen idec / Swedish Orphan Biovitrum (Sobi)

Therapy Class

Recombinant clotting factor therapy

Current Indication

Haemophilia B

Market Sector

Genetics

Development Status

Approved in the US and Canada
Expand

Go Top